Research And Development Tenders

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Peginterferon Beta-1A, Atc L03ab13 for the Period May 1St, 2023 - April 30Th, 2025

Open House Drug Rebate Contracts Formoterol and Aclidinium Bromide, Atc R03al05

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Finished Drug Smofkabiven, Atc B05ba10 for the Period May 1St, 2023 - April 30Th, 2025

Open House Discount Drug Contracts for Dexamethasone and Gentamicin, Atc S01ca21

Dynamic Purchasing System - Metals Revised

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for the Active Substance Interferon Beta-1A (Excl. for Intramuscular Injection), Atc L03ab07 for the Period May 1St, 2023 - April 30Th, 2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Tamsulosin Solifenacin, Atc G04ca53 for the Period May 1St, 2023 - April 30Th, 2025

Open House Drug Rebate Contracts Perindopril and Indapamide, Atc C09ba54

Open House Drug Rebate Contracts Formoterol and Fluticasone, Atc R03ak11

Dynamic Acquisition System for the Purchase of Private Vehicles